Literature DB >> 6882880

Intestinal lymphatic absorption of cyclosporin A following oral administration in an olive oil solution in rats.

C T Ueda, M Lemaire, G Gsell, K Nussbaumer.   

Abstract

The intestinal lymphatic absorption of cyclosporin A (CyA) following oral administration of 6.5 +/- 0.6 and 25.2 +/- 1.4 mg kg-1 doses of the drug dissolved in an olive oil solution was studied using a thoracic duct-cannulated rat model. Cumulative lymph samples were collected for up to 114 h post-dosing and assayed by liquid scintillation counting. In this study, the estimated amount of lymphatically absorbed CyA was 0.35 +/- 0.13 and 0.47 +/- 0.29 per cent of the respective doses. In terms of the overall oral bioavailability of CyA (Fpo) by all absorptive mechanisms, the intestinal lymphatics accounted for the absorption of approximately 2 per cent of the total amount of absorbed drug. Fpo was 21.3 +/- 2.5 per cent. The results of this study suggested that lipophilicity alone was not the only factor governing intestinal lymphatic drug absorption. An explanation for the low level of lymphatic CyA absorption is presented. In addition, some reasons for the low overall oral bioavailability of CyA are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6882880     DOI: 10.1002/bdd.2510040203

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  15 in total

Review 1.  Pharmacokinetic drug interactions with cyclosporin (Part II).

Authors:  G C Yee; T R McGuire
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

2.  The effect of food and bile acid administration on the relative bioavailability of cyclosporin.

Authors:  A Lindholm; S Henricsson; R Dahlqvist
Journal:  Br J Clin Pharmacol       Date:  1990-05       Impact factor: 4.335

3.  Enhanced intestinal absorption of cyclosporine in rats through the reduction of emulsion droplet size.

Authors:  B D Tarr; S H Yalkowsky
Journal:  Pharm Res       Date:  1989-01       Impact factor: 4.200

4.  Pharmacokinetics of oral cyclosporin A (Sandimmun) in healthy subjects.

Authors:  J Grevel; E Nüesch; E Abisch; K Kutz
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

5.  Exploring the impact of drug properties on the extent of intestinal lymphatic transport - in vitro and in vivo studies.

Authors:  Emma Lawless; Brendan T Griffin; Aoife O'Mahony; Caitriona M O'Driscoll
Journal:  Pharm Res       Date:  2014-11-27       Impact factor: 4.200

Review 6.  Drug absorption in gastrointestinal disease and surgery. Clinical pharmacokinetic and therapeutic implications.

Authors:  P O Gubbins; K E Bertch
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

7.  In vivo model for ciclosporin intestinal absorption in lipid vehicles.

Authors:  J P Reymond; H Sucker; J Vonderscher
Journal:  Pharm Res       Date:  1988-10       Impact factor: 4.200

8.  Lipophilic peptides: synthesis of lauroyl thyrotropin-releasing hormone and its biological activity.

Authors:  S Muranishi; A Sakai; K Yamada; M Murakami; K Takada; Y Kiso
Journal:  Pharm Res       Date:  1991-05       Impact factor: 4.200

9.  Modeling free energies of solvation in olive oil.

Authors:  Adam C Chamberlin; David G Levitt; Christopher J Cramer; Donald G Truhlar
Journal:  Mol Pharm       Date:  2008 Nov-Dec       Impact factor: 4.939

Review 10.  Cyclosporin clinical pharmacokinetics.

Authors:  A Fahr
Journal:  Clin Pharmacokinet       Date:  1993-06       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.